Astaxanthin has been observed to inhibit cell proliferation and induce apoptosis in several types of carcinoma cells, by decreasing the p-Akt/Akt ratio, thereby down-regulating Akt downstream signaling pathways, such as those of NF-κB, Wnt, and STAT3. Here, AKT1 is linked to carcinoma.